Therapeutic Plasma Exchange Market (By Disease Indication: Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders; By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027

CHAPTER 1. Industry Overview of Therapeutic Plasma Exchange
1.1. Definition and Scope
1.1.1. Definition of Therapeutic Plasma Exchange
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Therapeutic Plasma Exchange Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Therapeutic Plasma Exchange Market By Disease Indication
1.2.3. Therapeutic Plasma Exchange Market By End User
1.2.4. Therapeutic Plasma Exchange Market by Regions

CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Therapeutic Plasma Exchange Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Therapeutic Plasma Exchange Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019
4.2. R&D Status and Application Source of Therapeutic Plasma Exchange Major Manufacturers in 2019

CHAPTER 5. Therapeutic Plasma Exchange Market By Disease Indication
5.1. Introduction
5.2. Therapeutic Plasma Exchange Revenue By Disease Indication
5.2.1. Therapeutic Plasma Exchange Revenue (US$ Mn) and Forecast, By Disease Indication, 2016-2027
5.2.2. Neurological Disorders
5.2.2.1. Neurological Disorders Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Renal Disorders
5.2.3.1. Renal Disorders Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Hematology Disorders
5.2.4.1. Hematology Disorders Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Metabolic Disorders
5.2.5.1. Metabolic Disorders Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 6. Therapeutic Plasma Exchange Market Revenue By End User
6.1. Introduction
6.2. Therapeutic Plasma Exchange Revenue (US$ Mn) By End User
6.2.1. Therapeutic Plasma Exchange Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
6.2.2. Hospitals
6.2.2.1. Hospitals Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Specialty Clinics
6.2.3.1. Specialty Clinics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Ambulatory Surgical Centers
6.2.4.1. Ambulatory Surgical Centers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 7. North America Therapeutic Plasma Exchange Market By Country
7.1. North America Therapeutic Plasma Exchange Overview
7.2. U.S.
7.2.1. U.S. Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
7.2.2. U.S. Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
7.3. Canada
7.3.1. Canada Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
7.3.2. Canada Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
7.4. North America PEST Analysis

CHAPTER 8. Europe Therapeutic Plasma Exchange Market By Country
8.1. Europe Therapeutic Plasma Exchange Market Overview
8.2. U.K.
8.2.1. U.K. Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
8.2.2. U.K. Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.3. Germany
8.3.1. Germany Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
8.3.2. Germany Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.4. France
8.4.1. France Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
8.4.2. France Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.5. Spain
8.5.1. Spain Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
8.5.2. Spain Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.6. Rest of Europe
8.6.1. Rest of Europe Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
8.6.2. Rest of Europe Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.7. Europe PEST Analysis

CHAPTER 9. Asia Pacific Therapeutic Plasma Exchange Market By Country
9.1. Asia Pacific Therapeutic Plasma Exchange Market Overview
9.2. China
9.2.1. China Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
9.2.2. China Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.3. Japan
9.3.1. Japan Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
9.3.2. Japan Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.4. India
9.4.1. India Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
9.4.2. India Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.5. Australia
9.5.1. Australia Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
9.5.2. Australia Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.6. South Korea
9.6.1. South Korea Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
9.6.2. South Korea Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
9.7.2. Rest of Asia-Pacific Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.8. Asia Pacific PEST Analysis

CHAPTER 10. Latin America Therapeutic Plasma Exchange Market By Country
10.1. Latin America Therapeutic Plasma Exchange Market Overview
10.2. Brazil
10.2.1. Brazil Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
10.2.2. Brazil Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.3. Mexico
10.3.1. Mexico Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
10.3.2. Mexico Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.4. Rest of Latin America
10.4.1. Rest of Latin America Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 – 2027
10.4.2. Rest of Latin America Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027

CHAPTER 11. Middle East & Africa Therapeutic Plasma Exchange Market By Country
11.1. Middle East & Africa Therapeutic Plasma Exchange Market Overview
11.2. Saudi Arabia
11.2.1. Saudi Arabia Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
11.2.2. Saudi Arabia Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.3. UAE
11.3.1. UAE Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
11.3.2. UAE Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
11.4.2. Rest of Middle East & Africa Therapeutic Plasma Exchange Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027

CHAPTER 12. Player Analysis Of Therapeutic Plasma Exchange
12.1. Therapeutic Plasma Exchange Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Therapeutic Plasma Exchange Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 13. COMPANY PROFILE
13.1. Asahi Kasei Corporation
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2019
13.1.3.2. Asahi Kasei Corporation 2019 Therapeutic Plasma Exchange Business Regional Distribution
13.1.4. Product/ Service and Specification
13.1.5. Recent Developments & Business Strategy
13.1.6. Manufacturing Plant Footprint Analysis
13.2. Baxter International, Inc.
13.3. Terumo Corporation
13.4. B. Braun Melsungen AG
13.5. Fresenius Kabi AG
13.6. Kawasumi Laboratories, Inc.
13.7. Haemonetics Corporation
13.8. Cerus Corporation
13.9. Hemacare Corporation
13.10. Medica S.p.A.
13.11. Others